Abstract
How the Evidence Tipped SSRIs’ Risk-Benefit Balance: Clinical Perspective on Pediatric Depression
Weller E B~~Kang J~~Weller R A
This commentary provides a perspective on Columbia University’s report on classifying suicidality in selective serotonin reuptake inhibitor clinical trial data, how undisclosed clinical trial data tipped the risk-benefit balance in pediatric patients, & new data for using these drugs plus psychotherapy with adolescents with depression. (23 refs.)